← The Wire
MNPRNasdaq
Monopar Therapeutics
Pharmaceutical Preparations · DE · CIK 1645469
Monopar Therapeutics licenses and develops intellectual property for treatments, focusing on ALXN1840 for Wilson disease
$400M
Market cap
$94.56
Last close
+7.8%
1D
+37.7%
5D
120K
Volume
Price · last 39 sessions+73.1%
May 4L $54.64 · H $94.56Jun 29
187
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 26, 20268-KShareholder VoteJun 23, 20268-KReg FD DisclosureMay 29, 20268-KReg FD DisclosureMay 19, 202610-QFORM 10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14AFORM DEFA14AApr 30, 2026DEF 14AFORM DEF 14AApr 30, 20268-KReg FD DisclosureApr 20, 202610-K/AFORM 10-K/AApr 1, 20268-KResults of OperationsMar 27, 202610-KFORM 10-KMar 27, 20268-KReg FD DisclosureMar 2, 2026SC 13D/ASC 13D/AJan 30, 20268-KResults of OperationsNov 13, 202510-QFORM 10-QNov 13, 20258-KReg FD DisclosureNov 10, 20258-KMaterial Agreement · Reg FD DisclosureSep 24, 2025424B5FORM 424B5Sep 24, 20258-KReg FD DisclosureSep 15, 20258-KResults of OperationsAug 12, 202510-QFORM 10-QAug 12, 20258-KShareholder VoteJun 23, 2025DEFA14AFORM DEFA14AMay 23, 202510-QFORM 10-QMay 13, 20258-KResults of OperationsMay 13, 20258-KReg FD DisclosureMay 7, 2025DEF 14AFORM DEF 14AApr 30, 20258-KResults of OperationsMar 31, 202510-KFORM 10-KMar 31, 20258-KExecutive ChangeMar 3, 20258-KExecutive ChangeFeb 24, 20258-KMaterial Agreement · Equity IssuanceDec 23, 2024424B5FORM 424B5Dec 23, 20248-KReg FD DisclosureDec 6, 20248-KResults of OperationsNov 8, 202410-QFORM 10-QNov 8, 2024SC 13GSC 13GOct 31, 20248-KMaterial Agreement · Reg FD DisclosureOct 30, 2024424B5FORM 424B5Oct 29, 2024424B5FORM 424B5Oct 28, 2024SC 13GSC 13GOct 24, 20248-KMaterial Agreement · Acquisition / DispositionOct 24, 20248-KReg FD DisclosureOct 22, 20248-KReg FD DisclosureOct 15, 20248-KReg FD DisclosureOct 7, 20248-KReg FD DisclosureSep 12, 20248-KReg FD DisclosureAug 27, 20248-KReg FD DisclosureAug 21, 20248-KReg FD DisclosureAug 14, 202410-QFORM 10-QAug 9, 20248-KResults of Operations · Security-Holder RightsAug 9, 2024DEF 14AFORM DEF 14AJul 22, 20248-KReg FD DisclosureJul 9, 20248-KReg FD DisclosureJun 11, 20248-KReg FD DisclosureJun 10, 20248-KExecutive Change · Reg FD DisclosureMay 24, 202410-QFORM 10-QMay 9, 20248-KResults of OperationsMay 9, 20248-KReg FD DisclosureApr 16, 20248-KReg FD DisclosureApr 10, 202410-KFORM 10-KMar 28, 20248-KResults of OperationsMar 28, 20248-KReg FD DisclosureMar 7, 20248-KReg FD DisclosureMar 5, 20248-KDelisting NoticeFeb 28, 20248-KReg FD DisclosureFeb 27, 20248-KReg FD DisclosureFeb 22, 20248-KReg FD DisclosureFeb 20, 202410-QFORM 10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KReg FD DisclosureNov 1, 20238-KDelisting NoticeAug 30, 20238-KResults of OperationsAug 10, 202310-QFORM 10-QAug 10, 20238-KReg FD DisclosureAug 8, 20238-KReg FD DisclosureJul 11, 20238-KShareholder VoteJun 28, 2023SC 13GSC 13GJun 2, 20238-KReg FD DisclosureJun 1, 2023
Insider Activity
In the 90 days to Dec 26, 2025: 1 insider bought $105K · 1 sold $344K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Vu Quan AnhChief Financial Officer | Buy | 1,500 | $69.95 | $105K |
| Dec 18, 2025 | Klausner Arthur JDirector | Sell | 4,660 | $67.06 | $312K |
| Dec 18, 2025 | Klausner Arthur JDirector | Sell | 461 | $68.09 | $31K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance